Diabetic Clinic, B' Pediatric Department, University of Athens, P. & A. Kyriakou Children's Hospital, Athens, Greece.
Ups J Med Sci. 2009;114(4):214-20. doi: 10.3109/03009730903276381.
Type 1 diabetes mellitus (T1DM) is associated with an autoimmune reaction to thyroid antigens including thyroid peroxidase (anti-TPO) and thyroglobulin (anti-Tg).
We determined in children with T1DM the relationship of positive anti-thyroid antibodies to potential risk factors, including, age, gender, duration of diabetes, and glutamic acid decarboxylase antibodies (anti-GAD).
We studied 144 children and adolescents with T1DM. Their age was 12.3 +/- 4.6 (mean +/- SD) years, and duration of diabetes was 4.6 +/- 3.8 years. Anti-thyroid antibodies were determined using a luminescence method and anti-GAD using an enzyme-linked immunosorbent assay.
The prevalence rates of anti-thyroid antibodies among the children with T1DM in our study were: anti-TPO (17.4%), anti-Tg (11.1%), and of both anti-thyroid antibodies (10.4%). The presence of serum anti-thyroid antibodies was positively associated with age (16.6 years in those with positive tests versus 12.0 years in those with negative tests, P = 0.027), duration of diabetes (7.4 versus 4.3 years, P = 0.031), and serum TSH (Thyroid-stimulating hormone) levels (4.8 versus 2.3 microIU/mL, P = 0.002). The presence of both anti-thyroid antibodies was associated with female sex (boys: 4/75 (5.3%), girls: 11/69 (15.9%), chi-square = 6.44, P = 0.04). Subclinical autoimmune thyroiditis (SAIT) was present in 55.5% of the patients with thyroid antibody-positivity and was positively associated with age (16.6 versus 12.0 years, P = 0.001) and diabetes duration (7.6 versus 4.2 years, P = 0.001). Multiple logistic regression analysis revealed that the development of anti-thyroid antibodies was predicted by: 1) the presence of anti-GAD (odds ratio (OR) 1.45, 95% confidence interval (CI) 1.09-1.92), 2) the presence of a second anti-thyroid antibody (OR 134.4, 95% CI 7.7-2350.3), and 3) older age (OR 22.9, 95% CI 1.13-463.2).
Thyroid autoimmunity was associated with female gender, increasing age, long diabetes duration, the persistence of anti-GAD, and with TSH elevation, indicating subclinical hypothyroidism.
1 型糖尿病(T1DM)与甲状腺抗原的自身免疫反应有关,包括甲状腺过氧化物酶(抗 TPO)和甲状腺球蛋白(抗 Tg)。
我们在患有 T1DM 的儿童中确定了阳性抗甲状腺抗体与潜在危险因素之间的关系,包括年龄、性别、糖尿病持续时间和谷氨酸脱羧酶抗体(抗 GAD)。
我们研究了 144 名患有 T1DM 的儿童和青少年。他们的年龄为 12.3 ± 4.6(平均值 ± 标准差)岁,糖尿病持续时间为 4.6 ± 3.8 年。使用发光法测定抗甲状腺抗体,使用酶联免疫吸附试验测定抗 GAD。
在我们的研究中,患有 T1DM 的儿童抗甲状腺抗体的患病率为:抗 TPO(17.4%)、抗 Tg(11.1%)和两种抗甲状腺抗体(10.4%)。血清抗甲状腺抗体的存在与年龄呈正相关(阳性组为 16.6 岁,阴性组为 12.0 岁,P = 0.027)、糖尿病持续时间(阳性组为 7.4 年,阴性组为 4.3 年,P = 0.031)和血清 TSH(促甲状腺激素)水平(阳性组为 4.8 微 IU/mL,阴性组为 2.3 微 IU/mL,P = 0.002)。两种抗甲状腺抗体的存在与女性性别有关(男孩:4/75(5.3%),女孩:11/69(15.9%),卡方=6.44,P=0.04)。亚临床自身免疫性甲状腺炎(SAIT)存在于 55.5%的甲状腺抗体阳性患者中,与年龄呈正相关(16.6 岁与 12.0 岁,P=0.001)和糖尿病持续时间(7.6 岁与 4.2 岁,P=0.001)。多因素逻辑回归分析显示,抗甲状腺抗体的发展可由以下因素预测:1)抗 GAD 的存在(优势比(OR)1.45,95%置信区间(CI)1.09-1.92),2)第二种抗甲状腺抗体的存在(OR 134.4,95%CI 7.7-2350.3),和 3)年龄较大(OR 22.9,95%CI 1.13-463.2)。
甲状腺自身免疫与女性性别、年龄增长、糖尿病持续时间长、抗 GAD 持续存在以及 TSH 升高有关,提示亚临床甲状腺功能减退。